These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12738350)

  • 1. Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
    Ling W; Wesson DR
    Drug Alcohol Depend; 2003 May; 70(2 Suppl):S49-57. PubMed ID: 12738350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance medication for opiate addiction: the foundation of recovery.
    Bart G
    J Addict Dis; 2012; 31(3):207-25. PubMed ID: 22873183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2004; (3):CD002207. PubMed ID: 15266465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2003; (2):CD002207. PubMed ID: 12804429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid dependence treatment: options in pharmacotherapy.
    Stotts AL; Dodrill CL; Kosten TR
    Expert Opin Pharmacother; 2009 Aug; 10(11):1727-40. PubMed ID: 19538000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002207. PubMed ID: 18425880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A meta-analysis comparing the effectiveness of buprenorphine and methadone.
    West SL; O'Neal KK; Graham CW
    J Subst Abuse; 2000; 12(4):405-14. PubMed ID: 11452842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counselor training and attitudes toward pharmacotherapies for opioid use disorder.
    Aletraris L; Edmond MB; Paino M; Fields D; Roman PM
    Subst Abus; 2016; 37(1):47-53. PubMed ID: 26168816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2000; (3):CD002025. PubMed ID: 10908521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine in the treatment of opioid dependence.
    Davids E; Gastpar M
    Eur Neuropsychopharmacol; 2004 May; 14(3):209-16. PubMed ID: 15056480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
    Ling W; Wesson DR; Charuvastra C; Klett CJ
    Arch Gen Psychiatry; 1996 May; 53(5):401-7. PubMed ID: 8624183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine in the treatment of opiate dependence.
    Wesson DR; Smith DE
    J Psychoactive Drugs; 2010 Jun; 42(2):161-75. PubMed ID: 20648912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine for opioid dependence.
    Ling W
    Expert Rev Neurother; 2009 May; 9(5):609-16. PubMed ID: 19402772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.